Cost a focus as GSK takes lead in new wave of biotech lung drugs By: Reuters: Company News September 08, 2014 at 08:45 AM EDT * GSK drug ahead of similar ones from Teva and AstraZeneca Read More >> Related Stocks: Astrazeneca Plc ADR Gsk Plc ADR Rogers Corp Teva Pharmaceutical Industries ADR